Teleflex (TFX) Non Operating Interest Expenses (2009 - 2026)
Teleflex's (TFX) quarterly Non Operating Interest Expenses came in at $28.0 million in Q2 2026, up 28.8% on a YoY basis from $21.7 million in Q2 2025, and up 8.69% quarter-over-quarter from $25.7 million in Q1 2026.
Analysis
Teleflex (TFX) Non Operating Interest Expenses (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported Non Operating Interest Expenses for 18 consecutive years, with $28.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses rose 28.8% year-over-year to $28.0 million; the trailing twelve-month figure through Jun 2026 stood at $113.6 million (up 42.23% YoY), and the FY2025 full-year result was $100.2 million, up 20.01% from the prior year.
- Non Operating Interest Expenses climbed to $28.0 million in Q2 2026 per TFX's latest filing, from $25.7 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $31.8 million in Q3 2025 and bottomed at $10.4 million in Q1 2022.
- Historically, Non Operating Interest Expenses has averaged $20.9 million across 5 years, with a median of $21.1 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Non Operating Interest Expenses sank 37.98% in 2022, then surged 76.01% in 2023.
- Over 5 years, Non Operating Interest Expenses stood at $19.1 million in 2022, then surged by 35.01% to $25.7 million in 2023, then slipped by 27.68% to $18.6 million in 2024, then soared by 51.2% to $28.1 million in 2025, then fell by 0.63% to $28.0 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $28.0 million, $25.7 million, and $28.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.67 Bn | 175.07 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.14 Bn | 108.32 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 103.81 Bn | 100.34 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 63.52 Bn | 62.98 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.01 Bn | 31.55 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn | - |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Teleflex | 5.73 Bn | 5.43 Bn | 331.71 Mn | 27.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.95 Mn |
| Mar 31, 2026 | 25.72 Mn |
| Dec 31, 2025 | 28.13 Mn |
| Sep 28, 2025 | 31.84 Mn |
| Jun 29, 2025 | 21.70 Mn |
| Mar 30, 2025 | 18.54 Mn |
| Dec 31, 2024 | 18.60 Mn |
| Sep 29, 2024 | 21.06 Mn |
| Jun 30, 2024 | 21.17 Mn |
| Mar 31, 2024 | 22.68 Mn |
| Dec 31, 2023 | 25.72 Mn |
| Oct 1, 2023 | 23.19 Mn |
| Jul 2, 2023 | 17.76 Mn |
| Apr 2, 2023 | 18.34 Mn |
| Dec 31, 2022 | 19.05 Mn |
| Sep 25, 2022 | 13.38 Mn |
| Jun 26, 2022 | 11.42 Mn |
| Mar 27, 2022 | 10.42 Mn |
| Dec 31, 2021 | 12.01 Mn |
| Sep 26, 2021 | 11.99 Mn |